995
Views
12
CrossRef citations to date
0
Altmetric
Diabetes

Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis

, , , , , & show all
Pages 655-662 | Received 08 Dec 2015, Accepted 04 Feb 2016, Published online: 26 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Avivit Cahn, Simona Cernea & Itamar Raz. (2016) An update on DPP-4 inhibitors in the management of type 2 diabetes. Expert Opinion on Emerging Drugs 21:4, pages 409-419.
Read now

Articles from other publishers (11)

Enzo Bonora, Salvatore Cataudella, Giulio Marchesini, Roberto Miccoli, Olga Vaccaro, Gian P. Fadini, Nello Martini & Elisa Rossi. (2021) Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory. Nutrition, Metabolism and Cardiovascular Diseases 31:9, pages 2661-2668.
Crossref
Hui Shao, Michael Laxy, Stephen R. Benoit, Yiling J. Cheng, Edward W. GreggPing Zhang. (2021) Trends in Total and Out-of-pocket Payments for Noninsulin Glucose-Lowering Drugs Among U.S. Adults With Large-Employer Private Health Insurance From 2005 to 2018. Diabetes Care 44:4, pages 925-934.
Crossref
Parisa Pishdad, Reza Pishdad, Gholam Reza Pishdad & Yunes Panahi. (2020) A time to revisit the two oldest prandial anti-diabetes agents: acarbose and repaglinide. Endocrine 70:2, pages 307-313.
Crossref
Kyoung Lok Min, Heejo Koo, Jun Jeong Choi, Dae Jung Kim, Min Jung Chang & Euna Han. (2019) Utilization patterns of insulin for patients with type 2 diabetes from national health insurance claims data in South Korea. PLOS ONE 14:3, pages e0210159.
Crossref
Xiaowen Wang, Yaying Cao, Yao Wu, Chao Yang, Jing Song, Yaohua Tian, Mengying Wang, Man Li, Yiqun Wu & Yonghua Hu. (2019) The prescription pattern of initial treatment for type 2 diabetes in Beijing from 2011 to 2015. Medicine 98:8, pages e14370.
Crossref
V Bali, I Yermilov, A Koyama & A P Legorreta. (2018) Secondary prevention of diabetes through workplace health screening. Occupational Medicine 68:9, pages 610-616.
Crossref
Saleh Aldasouqi, Samia Mora, Gaurav Bhalla, Naveen Kakumanu, William Corser, George Abela, Mohammad Dlewati, Kathleen Estrada, Abdul Almounajed, Tarek Tabbaa, Jamal Hammoud & Cathy Newkirk. (2018) Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical Practice. International Journal of Endocrinology 2018, pages 1-6.
Crossref
W. Weng, Y. Liang, E. Kimball, T. Hobbs & S. Kong. (2018) Trends in comorbidity burden and treatment patterns in type 2 diabetes: Longitudinal data from a US cohort from 2006 to 2014. Diabetes Research and Clinical Practice 142, pages 345-352.
Crossref
Ricardo Saad Henriques, Laiza Maria Steimbach, Deise Regina Baptista, Luana Lenzi, Fernanda S. Tonin, Roberto Pontarolo & Astrid Wiens. (2018) DIRECT COSTS OF TYPE 2 DIABETES: A BRAZILIAN COST-OF-ILLNESS STUDY. International Journal of Technology Assessment in Health Care 34:2, pages 180-188.
Crossref
J.R. Anderson & G. Ray. 2018. Comprehensive Toxicology. Comprehensive Toxicology 419 431 .
Anne FinkBritta Haenisch. (2017) Oral antidiabetic drugs and dementia risk. Neurology 89:18, pages 1848-1849.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.